VUR Gel - DEXELL®

Injectable implant for the treatment of vesicoureteral reflux (VUR)

What is DEXELL® VUR?

After injection into the submucosa of the ureteral orifice, DEXELL® VUR forms a voluminous mass that prevents reflux. The dextranomer microparticles stimulate collagen production and fibroblast proliferation, leading to long-lasting tissue reinforcement at the injection site.

Description
Application

The gel is injected endoscopically through a cystoscope, directly beneath the mucosa around the ureteral orifice. Various injection techniques are available, such as STING (Subureteral Transurethral Injection) and HIT (Hydrodistention Implantation Technique), depending on the physician’s preference and the specific clinical situation.

Advantages of DEXELL® VUR
  • Minimally invasive treatment: Endoscopic injection without the need for open surgery.
  • Biocompatible and biodegradable: Made of materials that are safely absorbed by the body.
  • Stimulates tissue growth: Positively charged microparticles promote collagen production and fibroblast activity.
  • High success rates: Clinical studies show that DEXELL® VUR is effective in correcting VUR with minimal complications.
  • Rapid recovery: Patients can often go home the same day without the need for a bladder catheter.